Navigation Links
Gene signal GS-101 data shows safe and effective inhibition of ophthalmic blood vessel growth
Date:9/1/2009

Lausanne, Switzerland Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth). Neovascularisation in this part of the eye is a major risk factor in corneal graft rejection, the most common transplantation procedure that saves the sight of approximately 46,000 people worldwide each year.

The data were published in the September 2009 issue of Ophthalmology by researchers led by Claus Cursiefen, MD, from the Department of Ophthalmology at the Friedrich-Alexander University Erlangen-Nrnberg, in Erlangen, Germany. Gene Signal is now conducting an international phase III trial with GS-101 for the prevention of pathologic corneal neovascularisation and thereby corneal graft rejection. GS-101 has been granted Orphan Drug status for this indication in Europe.

"Compared to the placebo group in which 100% of patients suffered from progression of corneal neovascularisation, the optimal GS-101 treatment group showed regression in 86% of patients. We are very encouraged by these results as they represent real progress in the development of GS-101 as a new treatment to combat corneal graft rejection," explained Dr. Claus Cursiefen of the Department of Ophthalmology, Friedrich-Alexander University Erlangen-Nrnberg. "We urgently need new options for the thousands of graft recipients, whose current treatment options for threatened rejection such as immunosuppressants are not ideal due to side effects. GS-101 is the first specific angiogenesis inhibitor that has demonstrated activity at the anterior part of the eye, where numerous diseases associated with pathologic angiogenesis endanger vision."

"The publication of these positive phase II results for G
'/>"/>

Contact: Mike Sinclair
msinclair@halsin.com
44-200-845-955
Halsin Partners
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Scientists find clue to mechanisms of gene signaling and regulation
2. Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems
3. Researchers find signal that switches on eye development -- could lead to eye in a dish
4. Cell response to stress signals predicts tumors in women with common pre-breast cancer
5. Rong Li Lab reports protein interactions of MAP kinase signaling pathway
6. DNA variations signal lupus risk
7. Newly defined signaling pathway could mean better biofuel sources
8. Statistics are insufficient for study of proteins signal system
9. Science expands Science Signaling, featuring research related to medical advances, and more
10. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia
11. Presence of certain antibodies signals healthier teeth and gums
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... , May 25, 2015  Australia,s market for wearable ... although 2014 saw the advent of several trials and ... April 2015 is expected to ignite interest in wearables ... Australia . This in turn will ... and drive new partnerships amongst vendors and distributors. ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... key to the blinding effects of diabetic retinopathy is ... Georgia researchers said. Interleukin-6, known to contribute ... helps ignite inflammation of the retina, a first step ... blindness is working-age adults, MCG researchers reported online in ...
... of dollars each year on exotic smelling perfumes and lotions ... a new study in Psychological Science , a journal ... be the best way to capture a potential mate,s attention. ... habits: Animal studies have shown that male testosterone levels are ...
... Malaga have created the ,Inventory of Daily Stressors, a ... physical appearance, taking part in numerous extracurricular activities and ... that increase the risk of suffering from childhood stress. ... to assess daily stress amongst schoolchildren", Mara Victoria Trianes, ...
Cached Biology News:Discovery points toward anti-inflammation treatment for blinding disease 2A new method to measure childhood stress 2
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... on health care, Jack Uldrich has been selected ... in New York today. He will deliver his ... , Uldrich has delivered presentations to the American ... of Audiology and Neurology, Alcetel-Lucent/Verizon Forum on Wireless ...
(Date:6/1/2015)... and YONGIN, South Korea , June ... that Green Cross Biotherapeutics Inc. (GCBT) kicked off construction ... on the Montreal Technoparc,s Saint-Laurent Campus. The CA$315 million ... projects in Canada in the ... first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in ...
(Date:6/1/2015)... , June 1, 2015 ... the fermentation of sugar or cellulose. Bio-alcohols are primarily ... be used as a replacement for gasoline in cars. ... at a CAGR of 9 percent over the period ... global bio-alcohols market can be segmented into five: transportation, ...
(Date:6/1/2015)... , June 1, 2015 ... announced the addition of the "Global PDT ... offering.        (Logo: ... Report 2014 is a professional and in-depth study ... , ,The report provides a basic overview of ...
Breaking Biology Technology:Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3Global Bio-alcohols Market 2015-2019 2Global PDT Machine Industry Report 2014 2
... SAN FRANCISCO, Oct. 26 MedImmune, Inc. today ... Academy of Pediatrics (AAP),2007 National Conference & Exhibition, ... the prevention of respiratory syncytial virus (RSV), a,leading ... pleased to present data that provide key insights ...
... Healthcare Services,Inc. (NYSE: AHS ), the nation,s ... presentation on Tuesday, November 6, 2007 at 12:45 ... Annual Healthcare Conference,taking place at the Waldorf-Astoria Hotel ... ) Susan R. Nowakowski, President and Chief ...
... Required for Integra Merger, IRVINE, California, October 26 ... company, today reported that,less than 100,000 votes "FOR" are ... Holdings Corporation (NASDAQ: IART ),("Integra") pursuant to an ... 2007. Today,s special meeting of stockholders will remain ...
Cached Biology Technology:MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition 2MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition 3MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition 4MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition 5AMN Healthcare Services to Present at the CIBC World Markets 18th Annual Healthcare Conference 2IsoTis Reports Status of Merger Vote 2IsoTis Reports Status of Merger Vote 3IsoTis Reports Status of Merger Vote 4
XPC Immunogen: XPC (NP_004619, 141 a.a. ~ 251 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to Lck (phospho Y192) ( Abpromise for all tested applications). entrezGeneID: 3932 SwissProtID: P06239...
Anti 7H6 Antigen (tight-junction associated protein Antigen) Monoclonal Antibody 7H6...
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
Biology Products: